AACE MENA 2025-Diabetes and Ramadan: An Update

Video Transcription

Video Summary

The presentation addresses managing diabetes during Ramadan fasting, emphasizing individualized risk assessment and tailored care. Two patient cases illustrate differing challenges: a newly diagnosed diabetic with good control and a long-term diabetic on insulin with complications. Fasting impacts glucose regulation differently in diabetics due to altered pathophysiology and medication effects, with risks including hypoglycemia, hyperglycemia, dehydration, thrombosis, and ketoacidosis. Pre-Ramadan evaluation (6–8 weeks prior) involves risk stratification, education on glucose monitoring, diet, exercise, and medication adjustments, which vary by therapy type (e.g., metformin, sulfurylureas, SGLT2 inhibitors, GLP-1 analogs, insulin). Continuous glucose monitoring (CGM) is valuable for safe fasting. Special populations—pregnant women, elderly, advanced complications—require cautious or individualized approaches, often advising against fasting in high-risk cases. Post-Ramadan follow-up ensures appropriate therapy adjustments. Overall, with structured counseling, adherence to monitoring, and prudent medication management, people with diabetes can fast safely during Ramadan.

Keywords

Diabetes management

Ramadan fasting

Risk assessment

Glucose monitoring

Medication adjustment